Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pfister

Showing results (71-80 of 194) with videos related to

Pageof 20
Sort By:
Urologia Internationalis|March 17, 2021
Targeted Therapy in Patients with Metastatic Male Germ Cell TumorsAxel Heidenreich, Pia Paffenholz, Tim Nestler, et al.
European Urology Oncology|July 12, 2023
Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Metastatic Seminoma: Results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS)Axel Heidenreich, Pia Paffenholz, Florian Hartmann, et al.
Aktuelle Urologie|March 28, 2022
[Does robotic radical cystectomy affect oncological outcomes in bladder cancer patients?]David Mally, David Pfister, Axel Heidenreich, et al.
Polskie Archiwum Medycyny Wewnetrznej|October 23, 2009
Do alpha-reductase inhibitors prevent prostate cancer? 2008 practice guideline from the American society of clinical oncology and American urological associationDavid Thüer, David Pfister, Robin Epplen, et al.
Oncology Research and Treatment|December 4, 2015
Role of Focal Therapy with High-Intensity Focused Ultrasound in the Management of Clinically Localized Prostate CancerTimur H Kuru, Julius van Essen, David Pfister, et al.
Deutsches Arzteblatt International|October 25, 2012
Surgical resection of urological tumor metastases following medical treatmentAxel Heidenreich, Stefan Wilop, Michael Pinkawa, et al.
Aktuelle Urologie|August 1, 2024
[Clinical stage IIA/B seminoma - to do or not to do: the role of retroperitoneal lymphadenectomy]Axel Heidenreich, Felix Seelemeyer, Ruben Gößmann, et al.
The Journal of Urology|March 14, 2018
Testis Sparing Surgery for Benign Testicular Masses: Diagnostics and Therapeutic ApproachesPia Paffenholz, Linn Held, Sven H Loosen, et al.
Frontiers in Surgery|June 27, 2022
Comparative Analysis of Elderly Patients Undergoing Radical Cystectomy With Ureterocutaneostomy or Ileal Conduit With a Special Focus on Bowl Complications Requiring Surgical RevisionDavid Mally, Patricia John, David Pfister, et al.
Urologic Oncology|September 22, 2019
External validation of 2 models to predict necrosis/fibrosis in postchemotherapy residual retroperitoneal masses of patients with advanced testicular cancerPia Paffenholz, Tim Nestler, Simon Hoier, et al.
Pageof 20

Showing results (71-80 of 194) with videos related to

Sort By:
Pageof 20
Urologia Internationalis|March 17, 2021
Targeted Therapy in Patients with Metastatic Male Germ Cell TumorsAxel Heidenreich, Pia Paffenholz, Tim Nestler, et al.
European Urology Oncology|July 12, 2023
Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Metastatic Seminoma: Results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS)Axel Heidenreich, Pia Paffenholz, Florian Hartmann, et al.
Aktuelle Urologie|March 28, 2022
[Does robotic radical cystectomy affect oncological outcomes in bladder cancer patients?]David Mally, David Pfister, Axel Heidenreich, et al.
Polskie Archiwum Medycyny Wewnetrznej|October 23, 2009
Do alpha-reductase inhibitors prevent prostate cancer? 2008 practice guideline from the American society of clinical oncology and American urological associationDavid Thüer, David Pfister, Robin Epplen, et al.
Oncology Research and Treatment|December 4, 2015
Role of Focal Therapy with High-Intensity Focused Ultrasound in the Management of Clinically Localized Prostate CancerTimur H Kuru, Julius van Essen, David Pfister, et al.
Deutsches Arzteblatt International|October 25, 2012
Surgical resection of urological tumor metastases following medical treatmentAxel Heidenreich, Stefan Wilop, Michael Pinkawa, et al.
Aktuelle Urologie|August 1, 2024
[Clinical stage IIA/B seminoma - to do or not to do: the role of retroperitoneal lymphadenectomy]Axel Heidenreich, Felix Seelemeyer, Ruben Gößmann, et al.
The Journal of Urology|March 14, 2018
Testis Sparing Surgery for Benign Testicular Masses: Diagnostics and Therapeutic ApproachesPia Paffenholz, Linn Held, Sven H Loosen, et al.
Frontiers in Surgery|June 27, 2022
Comparative Analysis of Elderly Patients Undergoing Radical Cystectomy With Ureterocutaneostomy or Ileal Conduit With a Special Focus on Bowl Complications Requiring Surgical RevisionDavid Mally, Patricia John, David Pfister, et al.
Urologic Oncology|September 22, 2019
External validation of 2 models to predict necrosis/fibrosis in postchemotherapy residual retroperitoneal masses of patients with advanced testicular cancerPia Paffenholz, Tim Nestler, Simon Hoier, et al.
Pageof 20